AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1983344
Drug: Sufotidine 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufotidine 600 mg b.d. for 14 days
Trial: 28891826
Drug: 20 mL
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mL of 0.375% ropivacaine
Trial: 31820601
Drug: Jingtong granule
RxNorm normalized name: BUTYLENE GLYCOL 1.6 g in 8 g CUTANEOUS TAPE [LingLongJiuHuo Linglong Moxibustion]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jingtong granule (4 g, 3 times a day)
Trial: 23225093
Drug: Topical and
RxNorm normalized name: norgestimate and ethinylestradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical and intracameral anesthesia without sedation during first eye surgery
Trial: 23225093
Drug: Topical and
RxNorm normalized name: norgestimate and ethinylestradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical and intracameral anesthesia without sedation during second eye surgery
Trial: 21916971
Drug: Single or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single or double dose of MF59-adjuvanted influenza A(H1N1) vaccine
Trial: 21916971
Drug: Seasonal influenza
RxNorm normalized name: seasonal influenza, intradermal, preservative free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Seasonal influenza vaccine (virosome-adjuvanted trivalent influenza vaccine)
Trial: 21916971
Drug: Pandemic vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pandemic vaccine
Trial: 21916971
Drug: Local adverse
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Local adverse events at the injection site of pandemic vaccine
Trial: 21916971
Drug: Local adverse
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Local adverse events at the injection site of seasonal vaccine
Trial: 15853098
Drug: saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: saline solution
Trial: 12755970
Drug: Sunscreen cream
RxNorm normalized name: GLYCERIN 1 g in 50 g TOPICAL CREAM [SUNSCREEN Cream]
DrugBank: Homosalate (DB11064)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sunscreen cream use
Trial: 19309745
Drug: New chemotherapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New chemotherapeutic agents
Trial: 16805714
Drug: Biological agents
RxNorm normalized name: beremagene geperpavec
DrugBank: Beremagene geperpavec (DB17831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biological agents
Trial: 7984977
Drug: Beta-lactam antibiotics
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-lactam antibiotics for 10 days
Trial: 77367
Drug: Oral cromoglycate
RxNorm normalized name: cromoglycate
DrugBank: Cromoglicic acid (DB01003)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral cromoglycate
Trial: 26530268
Drug: Canagliflozin 200
RxNorm normalized name: Canagliflozin
DrugBank: Canagliflozin (DB08907)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Canagliflozin 200 mg
Trial: 18834673
Drug: Dose-escalated radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dose-escalated radiation and concurrent temozolomide
Trial: 15236782
Drug: Probenecid 250
RxNorm normalized name: probenecid 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probenecid 250 mg twice daily for seven days
Trial: 12049858
Drug: Fondaparinux 2.5
RxNorm normalized name: FONDAPARINUX 2.5MG/0.5ML INJ SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fondaparinux 2.5 mg, starting postoperatively
Trial: 12049858
Drug: Enoxaparin 40
RxNorm normalized name: ENOXAPARIN 40MG/0.4ML INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin 40 mg, starting preoperatively
Trial: 9804592
Drug: Naloxone (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (0.15 mg/kg iv)
Trial: 8983937
Drug: Capsule formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsule formulation of thiocolchicoside (8 mg)
Trial: 8983937
Drug: Tablet formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet formulation of thiocolchicoside (8 mg)
Trial: 794665
Drug: Hydergin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydergin (3 mg daily)
Trial: 17110814
Drug: STS 6
RxNorm normalized name: STS
DrugBank: Sodium tetradecyl sulfate (DB00464)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: STS 6 mg/24 h
Trial: 15322328
Drug: Alprostadil (PGE(1),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprostadil (PGE(1), Prostavasin, intravenous, infusion rate: 0.38 microg/h/kg)
Trial: 11285377
Drug: Prednisolone 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone 7.5 mg daily over 2 years
Trial: 31482684
Drug: Curcumin nanomicelle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin nanomicelle (40 mg, 3 times a day for 12 weeks)
Trial: 28187466
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg Mangifera indica fruit powder
Trial: 28187466
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg Mangifera indica fruit powder
Trial: 26133902
Drug: Chinese herbal
RxNorm normalized name: GINGER 28 mg in 100 mL TOPICAL OIL [Pain Relief Honzo Seika Chinese Herbal Aroma Oil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese herbal medicine (CHM), standardized extract of 7 selected ingredients, 5 capsules twice daily for 8 weeks.
Trial: 12540632
Drug: C-Peptide (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C-Peptide (600 nmol/24 h, four doses s.c.)
Trial: 11712303
Drug: Lidocaine administered
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine administered intravenously (single dose over 2 minutes)
Trial: 8174496
Drug: Cefuroxime (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefuroxime (1.5 g single dose)
Trial: 1813733
Drug: Cefoxitin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefoxitin (2 g triple dose)
Trial: 6181113
Drug: Ragweed allergoid
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ragweed allergoid administered in a clustered regimen
Trial: 6181113
Drug: Unaltered ragweed
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unaltered ragweed extract (allergen) in a weekly regimen
Trial: 31858126
Drug: Testosterone replacement
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone replacement therapy (intramuscular injections every 2 weeks for 22 weeks)
Trial: 31858126
Drug: Placebo (intramuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (intramuscular injections every 2 weeks for 22 weeks)
Trial: 21295880
Drug: Accelerated fractionation
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Accelerated fractionation (AF) - 1.1Gy+2.0Gy/day, 5days/week for 4.5weeks, total dose 68Gy
Trial: 21295880
Drug: Conventional fractionation
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional fractionation (CF) - 2Gy/day, 5days/week for 7 weeks, total dose 68Gy
Trial: 14961966
Drug: Ozonated autohemotherapy
RxNorm normalized name: ozone
DrugBank: Ozone (DB12510)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ozonated autohemotherapy (O3‐AHT) with ozone concentration of 50 micro g/ml
Trial: 3523663
Drug: 500 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 micrograms terbutaline in one inhalation
Trial: 31978126
Drug: Inspiratory Muscle
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inspiratory Muscle Training (IMT) - 30 breaths twice-daily at 50% of maximal inspiratory pressure (MIP) for 8 weeks
Trial: 31978126
Drug: Otago Exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Otago Exercise Program (OEP) - Resistance and mobility exercises for 60 minutes, twice-weekly for 8 weeks
Trial: 29419917
Drug: Ertugliflozin 5
RxNorm normalized name: ertugliflozin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ertugliflozin 5 mg/d
Trial: 29419917
Drug: Ertugliflozin 15
RxNorm normalized name: ertugliflozin 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ertugliflozin 15 mg/d
Trial: 25341356
Drug: Xuebijing Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xuebijing Injection 50 mL Bid
Trial: 20360607
Drug: Home-based rehabilitation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based rehabilitation program (4 physical therapy sessions)
Trial: 16002493
Drug: Standard physical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard physical therapy-supervised rehabilitation program (17 physical therapy sessions)
Trial: 12781412
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of Tc-99m labelled albumin particles before sterilization
Trial: 12781412
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of Tc-99m labelled albumin particles after sterilization
Trial: 1542501
Drug: Drug intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug intake during pregnancy (excluding pregnancy supplements)
Trial: 1542501
Drug: Hormonal support
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormonal support therapy
Trial: 1542501
Drug: Human teratogenic
RxNorm normalized name: Insulin Human
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human teratogenic drugs
Trial: 1542501
Drug: General drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General drug use during pregnancy
Trial: 3890282
Drug: Trimethoprim (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim (300 mg twice daily for five days)
Trial: 3890282
Drug: Co-trimoxazole (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-trimoxazole (two tablets twice daily for five days)
Trial: 27029912
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (CBT) (n = 48)
Trial: 22805100
Drug: 60 mg/d
RxNorm normalized name: cabozantinib s-malate 60 mg/day (20 mg x 3/day) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg/d oral prednisone for 14 days with a 5‐day taper (121 patients)
Trial: 22805100
Drug: 4 IT
RxNorm normalized name: IT-139
DrugBank: IT-139 (DB17145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 IT doses for 14 days of 40 mg/ml methylprednisolone (129 patients)
Trial: 12432178
Drug: Bovine colostrum
RxNorm normalized name: Bovine Colostrum
DrugBank: Bos taurus colostrum (DB19249)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bovine colostrum (BC; 60 g day-1)
Trial: 12432178
Drug: Concentrated whey
RxNorm normalized name: whey protein hydrolysate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concentrated whey protein powder (WP; 60 g day-1)
Trial: 6744778
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg HCTZ/amiloride 2.5 mg
Trial: 6744778
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg HCTZ alone
Trial: 6744778
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg HCTZ/amiloride 2.5 mg (higher dose)
Trial: 30702519
Drug: Daily protein-calorie
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily protein-calorie supplement and micronutrient supplement
Trial: 30702519
Drug: Micronutrient supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronutrient supplement only
Trial: 30201853
Drug: 48 g
RxNorm normalized name: GLYCERIN 3 g in 48 g CUTANEOUS OINTMENT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 48 g Casein Protein (CP)
Trial: 30201853
Drug: 24 g
RxNorm normalized name: glucose 24 g/31 g oral gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24 g Casein Protein (CP)
Trial: 30201853
Drug: 24 g
RxNorm normalized name: glucose 24 g/31 g oral gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24 g Whey Protein (WP)
Trial: 30201853
Drug: 48 g
RxNorm normalized name: GLYCERIN 3 g in 48 g CUTANEOUS OINTMENT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 48 g Whey Protein (WP)
Trial: 24650926
Drug: Aortic pressure-guided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aortic pressure-guided treatment (active, n=23)
Trial: 24650926
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (control, n=27)
Trial: 24650926
Drug: Aortic pressure-guided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aortic pressure-guided treatment (active)
Trial: 17870636
Drug: 3-day oral
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3-day oral quinine-clindamycin
Trial: 12244905
Drug: Daily site
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily site care with povidone-iodine 10% solution and new sterile gauze (Group II)
Trial: 12244905
Drug: Total parenteral
RxNorm normalized name: TPN - total parenteral nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total parenteral nutrition administration
Trial: 12244905
Drug: Coexisting malignancy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coexisting malignancy or diabetes mellitus, duration of catheter, antibiotics use
Trial: 10416046
Drug: CoQ10 100
RxNorm normalized name: Walgreens CoQ10 100mg Softgel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CoQ10 100 mg bid
Trial: 7580834
Drug: HGP‐30 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HGP‐30 vaccine (10 and 25 micrograms/kg)
Trial: 7580834
Drug: HGP‐30 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HGP‐30 vaccine (50 and 100 micrograms/kg)
Trial: 7580834
Drug: HGP‐30 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HGP‐30 vaccine
Trial: 2164934
Drug: Ketoconazole tablets
RxNorm normalized name: Ketoconazole Tablets
DrugBank: Ketoconazole (DB01026)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketoconazole tablets every 8 hours for six doses
Trial: 2164934
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol patch
Trial: 2164934
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ketoconazole and transdermal estradiol
Trial: 31422390
Drug: Dexamethasone plus
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone plus antibiotic
Trial: 31422390
Drug: Antibiotic and
RxNorm normalized name: Triple Antibiotic And Pain Relief
DrugBank: Polymyxin B (DB00781)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antibiotic and placebo (Control)
Trial: 29525907
Drug: Intralesional injection
RxNorm normalized name: DEXAMETHASONE SODIUM PHOSPHATE 4 mg in 1 mL INTRALESIONAL INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional injection of 10 mg/ml triamcinolone (steroid)
Trial: 29525907
Drug: Intralesional injection
RxNorm normalized name: DEXAMETHASONE SODIUM PHOSPHATE 4 mg in 1 mL INTRALESIONAL INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional injection of 1 ml autologous platelet-rich plasma (PRP)
Trial: 29525907
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (PRP and ILS)
Trial: 26574953
Drug: Dutasteride (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutasteride (0.5 mg od)
Trial: 26574953
Drug: Finasteride (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finasteride (5 mg od)
Trial: 24964392
Drug: Darunavir/cobicistat fixed-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darunavir/cobicistat fixed-dose combination (FDC) 800 mg/150 mg
Trial: 24964392
Drug: Darunavir (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darunavir (800 mg) and cobicistat (150 mg) as single agents
Trial: 22368231
Drug: Rituximab (RTX)
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rituximab (RTX) treatment with methotrexate after 1 g infusion on days 1 and 15
Trial: 22368231
Drug: Rituximab (RTX)
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rituximab (RTX) treatment in rheumatoid factor-positive patients
Trial: 20022717
Drug: Massage therapy
RxNorm normalized name: CAMPHOR (SYNTHETIC) 30 g in 1 mL / MENTHOL 40 g in 1 mL TOPICAL OIL [CBDMEDIC MASSAGE THERAPY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Massage therapy by mothers plus skin‐to‐skin care (Intervention Group)
Trial: 17404083
Drug: Ketoconazole treatment
RxNorm normalized name: Ketoconazole
DrugBank: Ketoconazole (DB01026)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketoconazole treatment
Trial: 16334808
Drug: Enprostil 25
RxNorm normalized name: enprostil
DrugBank: Enprostil (DB13824)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enprostil 25 microg b.i.d. and cimetidine 400 mg b.i.d. for 8 weeks
Trial: 16334808
Drug: Cimetidine 400
RxNorm normalized name: cimetidine 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 400 mg b.i.d. alone for 8 weeks
Trial: 12494804
Drug: Bilateral ilioinguinal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilateral ilioinguinal nerve block with 15 ml x 2 of 0.25% bupivacaine
Trial: 12494804
Drug: Subcutaneous 1
RxNorm normalized name: IgG, human subcutaneous 16 % Injectable Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous 1 mg kg‐1 of tramadol
Trial: 2945420
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg nicorandil
Trial: 20685043
Drug: 1mg IV
RxNorm normalized name: bortezomib
DrugBank: Bortezomib (DB00188)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: 1mg IV cortisol infusion
Trial: 15147434
Drug: Fluvastatin (40-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin (40-80 mg/day)
Trial: 7694321
Drug: Mono-chemotherapy
RxNorm normalized name: tiotropium bromide mono
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mono-chemotherapy
Trial: 23571496
Drug: Pegylated filgrastim
RxNorm normalized name: Filgrastim
DrugBank: Filgrastim (DB00099)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Pegylated filgrastim 100 µg/kg
Trial: 25820754
Drug: Filgrastim 5
RxNorm normalized name: Filgrastim
DrugBank: Filgrastim (DB00099)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Filgrastim 5 µg/kg/day
Trial: 20033901
Drug: Brief problem-solving
RxNorm normalized name: Solv X
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brief problem-solving treatment by primary care doctors (PST-PC)
Trial: 16919061
Drug: Medication overuse
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medication overuse headache (MOH)
Trial: 16919061
Drug: Triptan-induced medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triptan-induced medication overuse headache (MOH)
Trial: 15265052
Drug: Hyperbaric oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric oxygen therapy (3 sessions)
Trial: 15265052
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (3 hyperbaric air treatments)
Trial: 15265052
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (hyperbaric air treatments)
Trial: 8331200
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of 20 mg
Trial: 8331200
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of 40 mg
Trial: 8331200
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of 80 mg
Trial: 8331200
Drug: Multiple dose
RxNorm normalized name: Rebetron, multiple dose 600 mg/day oral and injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple dose administration of 40 mg/day for 5 days
Trial: 8331200
Drug: Multiple dose
RxNorm normalized name: Rebetron, multiple dose 600 mg/day oral and injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple dose administration of 80 mg/day for 5 days
Trial: 8331200
Drug: Multiple dose
RxNorm normalized name: Rebetron, multiple dose 600 mg/day oral and injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple dose administration of 160 mg/day for 5 days
Trial: 31533818
Drug: Pembrolizumab 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pembrolizumab 200 mg intravenously every 3 weeks
Trial: 28970147
Drug: Fructans (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fructans (0.5 g/kg; maximum, 19 g)
Trial: 12492188
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg p.o. b.i.d. for 6 weeks